title: HLA-B27 in patients with a permanent pacemaker.
authors.forename: J
authors.initials: J
authors.lastname: Bruges-Armas
authors.forename: C
authors.initials: C
authors.lastname: Lima
authors.forename: D
authors.initials: D
authors.lastname: Simas Lopes
authors.forename: V
authors.initials: V
authors.lastname: Schneider
authors.forename: J P
authors.initials: JP
authors.lastname: Paisana Lopes
authors.forename: A
authors.initials: A
authors.lastname: Ferreira Gomes
authors.forename: J G
authors.initials: JG
authors.lastname: Coelho Gil
authors.forename: M J
authors.initials: MJ
authors.lastname: Barreiros
authors.forename: M J
authors.initials: MJ
authors.lastname: Peixoto
authors.forename: F
authors.initials: F
authors.lastname: Garrett
authors.forename: F
authors.initials: F
authors.lastname: Laranjeira
authors.forename: A R
authors.initials: AR
authors.lastname: Couto
authors.forename: T W
authors.initials: TW
authors.lastname: O'Neill
authors.forename: G
authors.initials: G
authors.lastname: Herrero-Beaumont
mesh_terms: D000368:Aged; D001145:Arrhythmias, Cardiac / Q000276:immunology / Q000628:therapy*; D016022:Case-Control Studies; D005260:Female; D015796:HLA-B27 Antigen / Q000032:analysis*; D006801:Humans; D008297:Male; D010138:Pacemaker, Artificial; D025242:Spondylarthropathies / Q000276:immunology / Q000628:therapy*
chemical_list: D015796:HLA-B27 Antigen